Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01950650 · ClinicalTrials.gov registry record
GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 1,800
- Enrollment target
NCT01950650: Completed study, sponsored by Novo Nordisk A/S.
NCT01950650 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 1,800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01950650 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 1,800 participants
- Enrollment target
Study Summary
This study is conducted in Asia, Europe and in the United States of America. The aim of this study is to examine patient and physician beliefs regarding insulin therapy and the degree to which patients adhere to their insulin regimens.
Interventions
- BEHAVIORAL survey
- BEHAVIORAL No treatment given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,800 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-09 |
What the finished NCT01950650 record still lists
NCT01950650 is an observational study that tracks outcomes without assigning an intervention. Its 1,800 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which survey is the first listed.
NCT01950650 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01950650 about?
NCT01950650 is a clinical study titled "GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus". This study is conducted in Asia, Europe and in the United States of America. The aim of this study is to examine patient and physician beliefs regarding insulin therapy and the degree to which patients adhere to their insulin regimens.
What is the current status of trial NCT01950650?
This trial is currently completed. The enrollment target is 1,800 participants. The study started on 2010-03. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01950650?
The interventions under investigation include: survey (BEHAVIORAL), No treatment given (BEHAVIORAL).
Who is sponsoring clinical trial NCT01950650?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
- NCT05258656 · 1,800 participants · NA
Childhood Activities Nutrition and Development Oversight
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia